2018 annual financial data
Viridian Therapeutics 2018 Net margin
Direct answer
Net margin was -389.97%.
Operating income was -33.08M USD and net income was -32.7M USD.
Operating cash flow was -26.84M USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8.39M USD
- Operating income
- -33.08M USD
- Net income
- -32.7M USD
- Operating cash flow
- -26.84M USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Viridian Therapeutics financial years